20 related articles for article (PubMed ID: 8848243)
1. The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System.
Hagen KM; Ousman SS
Front Aging Neurosci; 2020; 12():613628. PubMed ID: 33584245
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.
Plomp JJ; Willison HJ
J Physiol; 2009 Aug; 587(Pt 16):3979-99. PubMed ID: 19564393
[TBL] [Abstract][Full Text] [Related]
3. Acute ophthalmoparesis in the anti-GQ1b antibody syndrome: electrophysiological evidence of neuromuscular transmission defect in the orbicularis oculi.
Lo YL; Chan LL; Pan A; Ratnagopal P
J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):436-40. PubMed ID: 14966161
[TBL] [Abstract][Full Text] [Related]
4. Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective.
O'Hanlon GM; Bullens RW; Plomp JJ; Willison HJ
Neurochem Res; 2002 Aug; 27(7-8):697-709. PubMed ID: 12374204
[TBL] [Abstract][Full Text] [Related]
5. Campylobacter species and Guillain-Barré syndrome.
Nachamkin I; Allos BM; Ho T
Clin Microbiol Rev; 1998 Jul; 11(3):555-67. PubMed ID: 9665983
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune responses in peripheral nerve.
Hartung HP; Willison H; Jung S; Pette M; Toyka KV; Giegerich G
Springer Semin Immunopathol; 1996; 18(1):97-123. PubMed ID: 8984683
[No Abstract] [Full Text] [Related]
7. Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals.
Buchwald B; Weishaupt A; Toyka KV; Dudel J
Eur J Neurosci; 1998 Jan; 10(1):281-90. PubMed ID: 9753137
[TBL] [Abstract][Full Text] [Related]
8. Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome.
Buchwald B; Bufler J; Carpo M; Heidenreich F; Pitz R; Dudel J; Nobile-Orazio E; Toyka KV
Neurology; 2001 Jan; 56(1):67-74. PubMed ID: 11148238
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.
Buchwald B; Toyka KV; Zielasek J; Weishaupt A; Schweiger S; Dudel J
Ann Neurol; 1998 Dec; 44(6):913-22. PubMed ID: 9851436
[TBL] [Abstract][Full Text] [Related]
10. Differential blocking effects of the monoclonal anti-GQ1b IgM antibody and alpha-latrotoxin in the absence of complement at the mouse neuromuscular junction.
Buchwald B; Ahangari R; Toyka KV
Neurosci Lett; 2002 Dec; 334(1):25-8. PubMed ID: 12431767
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular blockade by immunoglobulin G from patients with Miller Fisher syndrome.
Buchwald B; Dudel J; Toyka KV
Ann N Y Acad Sci; 1998 May; 841():659-69. PubMed ID: 9668311
[No Abstract] [Full Text] [Related]
12. Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice.
Buchwald B; Weishaupt A; Toyka KV; Dudel J
Neurosci Lett; 1995 Dec; 201(2):163-6. PubMed ID: 8848243
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
